Point-of-Care Testing (POCT) has transformed modern healthcare by enabling rapid, accurate diagnostic testing at or near the patient, facilitating timely clinical decision-making and improving patient outcomes. Widely used in infectious disease diagnosis, emergency medicine, and decentralized healthcare settings, POCT enhances access to diagnostics while reducing turnaround times and dependence on centralized laboratories. This track highlights recent advances in rapid diagnostics, molecular point-of-care technologies, biosensors, artificial intelligence, and their applications in infectious disease detection, outbreak response, and personalized patient care.
Market Analysis: The global point-of-care testing (POCT) market is estimated to be valued at USD 46.7 billion in 2025 and is projected to reach approximately USD 78.5 billion by 2030, growing at a CAGR of 11.0% during the forecast period. Market growth is driven by increasing demand for rapid infectious disease diagnostics, expanding adoption of portable molecular testing platforms, advancements in AI-enabled diagnostic devices, and the growing need for decentralized healthcare services. North America continues to lead the market due to widespread clinical adoption and advanced healthcare infrastructure, while the Asia-Pacific region is expected to witness the fastest growth, supported by expanding healthcare access, government initiatives, and rising investments in diagnostic technologies.
ALSO READ Infectious Diseases and Global Health Viral Infections Bacterial Infections Fungal Infections Vector-borne Diseases Virology and HIVAIDS Immunology and Clinical Microbiology Antiviral Drug Resistance Catheter-Associated Urinary Tract Infection Emerging Infectious Diseases Hospital-Acquired Infections HAIs Maternal-Fetal Infections Next-Generation Antibiotics Pediatric Infectious Diseases Sepsis Diagnosis and Care Zoonotic Diseases Neurological and CNS Infections Healthcare-Associated Infections Ophthalmological Infectious Diseases Lower Respiratory and Pediatric IDs Genomics and Infectious disease Special Session on COVID-19 Vaccines and Immunizations Antibiotic Sensitivity Testing Blood-Borne Disease Contagious Disease Encephalitis Global Pandemic Preparedness Influenza Surveillance Systems Microbiome and Immunity Occupational Safety and Health OSH Point-of-Care Testing POCT Travel-Related Infections Tropical Diseases and Parasitic Diseases Sexually Transmitted Diseases and STIs Pathophysiology and Diagnosis Clinical Trials and Case Studies Influencing Factors of IDs Advanced Treatments and Technologies Oral and Maxillofacial Infections Prevention and Control Public Health and Epidemiology Artificial Intelligence in ID Climate Change and Infections Gastroenteritis HIV and Co-Infections Malaria Elimination Strategies Neglected Tropical Diseases NTDs One Health Approach Rapid Diagnostic Innovations Tuberculosis Drug Resistance
Tags
Entomology Conferences
Infectious Disease Conferences
Parasitology Conferences
Bacteriology Conferences
HIV/AIDS Conferences
Virology Conferences
Infectious Disease Conferences USA
Infectious Disease Conferences 2026 Asia
Epidemiology Conferences
Vector-Borne Diseases Conferences
Microbiology Conferences
Influenza Conferences
Pathology Conferences
Infection Conferences 2027